As shown in scheme S1, firstly, the amino protection reaction of L-serine or D-serine with di-tert-butyl carbonate in a mixture of 1M NaOH aq. and dioxane gave compounds 6L,D. [1] Then the carboxyl group was protected by esterification with 2-tert-Butyl-1,3-diisopropylisourea in THF at room temperature to give compounds 7L,D. [2, 3] Next, the obtained amino β-alcohols were reacted with thionyl chloride in the presence of triethylamine under the catalysis of imidazole to afford the intermediate cyclicsulfamidites which were subsequently oxidized by sodium periodate with catalytic ruthenium(III) chloride to give cyclic-sulfamidates 3L,D. [4] With the desired cyclic-sulfamidates in hand, we immediately set out to investigate whether these compounds were applicable substrates for the exogenous-fluoridemediated nucleophilic trifluoromethylthiolation reaction. Much to our delight, the ringopening reaction of these cyclic-sulfamidates 3L,D proceeded smoothly in the presence of PDFA (Ph 3 
1) Potassium 2-bromo-2,2-difluoroacetate
To a solution of potassium hydroxide (2.80 g, 50.00 mmol) in methanol (50 mL) was slowly dropped ethyl 2-bromo-2,2-difluoroacetate (10.25 g, 50.50 mmol) at 0 o C.
Afterward, the mixture was naturally warmed to room temperature and stirred for 18 h.
The organic solvent was removed, and the residue was further dried under vacuum to obtain a white powder (16.90 g, 95%), which was directly used in the next reaction without further purification.
Note:
The white powder is easy to absorb moisture. 
2) 2,2-difluoro-2-(triphenylphosphonio)acetate (PDFA)

3) (tert-butoxycarbonyl)-L-serine 6L
To a solution of L-serine (10.5 g, 100 mmol) in 1M NaOH aq. (200 mL) and dioxane (100 mL) was slowly added ditertbutyldicarbonate (21.8 g, 100 mmol). The mixture was stirred for overnight at room temperature. The reaction solution was washed with diethyl ether (3 × 100 mL). Then the aqueous phase was acidified to pH = 3 with 1N
HCl aq., extracted with ethyl acetate (3 × 200 mL). The combined organic phase was washed with water (300 mL), brine (300 mL) and dried over Na 2 SO 4 , then evaporated the solvent to afford a colorless oil (18.46 g, 90%) .
[α] D 22 6.58 (c 1.0, CHCl 3 ).
4) tert-butyl (tert-butoxycarbonyl)-L-serinate 7L
To a solution of (tert-butoxycarbonyl)-L-serine (8.20 g, 40 mmol) in anhydrous THF (100 mL) was slowly added O-tert-Butyl-N, N'-diisopropylisourea (20.03 g, 100 mmol).
Then the mixture was stirred for 4 h at room temperature. 
6) tert-butyl N-(tert-butoxycarbonyl)-S-(trifluoromethyl)-L-cysteinate 9L
To a 20 mL sealed tube were added di-tert-butyl (4S)-1,2,3-oxathiazolidine-3,4- 
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Analysis of hydrolysis reaction mixture by using TLC (ethyl acetate/petroleum ether 1:30 as the developing solvent).
Note 1:
To isolate the CF 3 -product (easily soluble in petroleum ether) from Ph 3 P=S (triphenylphosphorus sulfide, slightly soluble in petroleum ether). It is necessary for the crude product to wash with cold petroleum ether.
Note 2:
The short column chromatography was gradually eluted from petroleum ether to petroleum ether/ethyl acetate 100: 1. It's necessary to use a large amount of petroleum ether (about 5~6 L) throughout the purification process.
Note 3:
Redistilled petroleum ether could effectively decrease the residual solvents (high-boiling point) in the final product.
8) S-(trifluoromethyl)-L-cysteine 10L
To a solution of tert-butyl N-(tert-butoxycarbonyl)-S-(trifluoromethyl)-L-cysteinate (69 mg, 0.2 mmol) in anhydrous dichloromethane (1.0 mL) was added Trifluoroacetic acid (TFA, 3 mL), and the reaction mixture was stirred at room temperature. After stirring for 6 h, the solvent was removed under high vacuum, anhydrous diethyl ether (10 mL) was added to the residue. The crude S-CF 3 -L-CYS was filtered (syringe filter, PTFE, 25 mm diameter, 0.45 μm), then washed with diethyl ether (2 × 10 mL), and finally dissolved with methanol (2 × 10 mL). The organic solvent was concentrated in vacuo to give the title product as a white powder (36 mg, 95% 
10) tert-butyl (tert-butoxycarbonyl)-D-serinate 7D
The synthetic procedure of 7D was the same with that of 7L. 
11) di-tert-butyl (4R)-1,2,3-oxathiazolidine-3,4-dicarboxylate 2,2-dioxide 3D
The synthetic procedure of 3D was the same with that of 3L. 
12) tert-butyl N-(tert-butoxycarbonyl)-S-(trifluoromethyl)-D-cysteinate 9D
The synthetic procedure of 9D was the same with that of 9L. 
13) S-(trifluoromethyl)-D-cysteine 10D
The synthetic procedure of 10D was the same with that of 10L. (Table S1 , entries 1-2). Subsequent attempts found that the RCY of 4L increased with the reaction time extending, but no apparent increases beyond 5 minutes (entries 3-4). The use of additives to further optimize the reaction conditions was of no obvious positive impact on the reaction yields (entries 5-7). After that, the investigation of solvent effect indicated that using DMF couldn't give higher RCY (entries 8-9), mainly because the polar intermediate 4L wasn't easily trapped by the C18 cartridge in the presence of DMF, even if be diluted by water at least 20-fold. Thus, it may not be so helpful to use solvents with a higher polarity in the preparation of 2L
and 2D. Moreover, we knew that the increase of stoichiometric ratio might be favorable for the improvement of RCY, but this was not optimal because the insoluble substances
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would rise accordingly; and as such, we had been committed to exploring this reaction under low stoichiometry conditions. 
2) Apparatus and Sep Pak cartridges used for the radiosynthesis of 2L and 2D
Equipment for the nucleophilic [ As illustrated in Scheme S2, serine-derived cyclic sulfamidates (3L and 3D) were used as chiral synthons for the synthesis of 18 F-trifluoromethylated cysteines (2L and 2D).
2L and 2D were synthesized stereoselectively from the serine-derived cyclic sulfamidates 3L and 3D via a nucleophilic 18 F-trifluoromethylthiolation reaction followed by a deprotection reaction.
Radio-TLC analysis of the radiochemical purity
The radiochemical purity of S-[ 18 F]CF 3 -L-CYS or S-[ 18 F]CF 3 -D-CYS was determined
by radio-Thin Layer Chromatography (radio-TLC). Radio-TLC was carried out using aluminum sheets pre-coated with silica gel 60 F254 (E. Merck, Germany).
Solvent system: acetonitrile/methanol/water (40:10:10) 
2) HPLC analysis of S-[ 18 F]CF 3 -CYS enantiomers using the test tube method
To further improve the detection sensitivity (radioactive signal), the test tube method [6] was used for HPLC analysis of S-[ 18 F]CF 3 -CYS enantiomers. As shown in the figure below, HPLC samples were collected in 30-second fractions by using the test tube (10 mL) for 20 min. All the samples were counted using a γ-counter for 20 s. The counts were decay-corrected to the initial injection time and added together. The radioactivity counts were expressed as the plotted intensity (cpm) versus fractions to show the profile of the sample. The data were plotted to reconstruct the HPLC spectrum by using Origin ® 9 (a complete graphing and data analysis software). The results further confirmed that almost no racemization was detected. 
Determination of partition coefficients (logP)
The partition coefficients for each enantiomers (2L or 2D) were determined by adding radiotracer solution (20 μL, 5 μCi; 0.19 MBq) to an equal volume (n-octanol/water; 5 mL/5 mL) mixture. The mixture was vortexed vigorously for 5 min and then centrifuged at 3000 rpm for 15 min. Aliquot of 300 μL n-octanol or 300 μL water was taken out from each phase, then respectively counted by the γ-counter, taking care to avoid cross-contamination and interaction effect between two phases. The partition coefficients were calculated according to the formula: logP = log 10 (counts of noctanol/counts of water) and reported by averaging nine measurements.
Cell culture
The C6 glioma cell line was kindly provided by the Cell Bank of the Chinese Academy of Sciences in Shanghai. All cells were cultured in Dulbecco's modified Eagle's medium (DMEM, GIBCO) supplemented with 10% fetal bovine serum (FBS, GIBCO), 1% 100 μg/ml streptomycin and 100 IU/ml penicillin (MRC) at 37 °C in the humidified circumstance containing 5% CO 2 . When cells reached 90% confluence in the logarithmic growth phase, they were harvested or passaged. Four-to six-week-old male nude mice of BALB/c origin were purchased from Beijing Vital River Laboratory Animal Technology Co., Ltd. To establish C6 tumor models, they were subcutaneously implanted 5 × 10 6 C6 cells in 0.1 ml of PBS into the right shoulder flanks. When the tumor size reached 0.6-1.0 cm in diameter (about 2-3 weeks after inoculation), animals were subjected to studies.
C6 tumor-bearing mice models
Turpentine-induced inflammation
Eight Kunming mice (6-8 weeks old, 25-30 g weight) were used to induce aseptic inflammatory models. Turpentine (0. ). The uptake ratios of inflammation-to-muscle, and inflammationto-blood were also calculated. Experiments were performed three times with quadruplicate wells.
Competitive cell uptake assay
C6 cells at a density of 1×10 5 cells/well were seeded into 24-well plates 24 h prior to experiments, which were repeated three times with quadruplicate wells for each group. the uptake data (expressed as a percentage of the injected dose per 100 microgramm of protein, % ID/100 μg protein) = (the final measured radioactivity/the decay-corrected radioactivity originally added)/protein content. And the final uptake values of every group were averaged and expressed as the percentage of the uptake of the Na + -containing control group, which was supposed to be 100%.
Protein incorporation assay
time point) were sacrificed by cervical dislocation at various times (5, 30, 60 and 90 min after injection of 2L and 2D). The organs of interest (blood, brain, heart, lung, liver, spleen, pancreas, kidney, stomach, intestine, bone and muscle) were rapidly dissected and weighed, and the radioactivity was counted with a γ-counter. All measurements were background-subtracted and decay-corrected to the time of injection, and the values were expressed as percent of injected dose per gram of wet tissue (% ID/g).
Small-animal PET imaging studies
In vivo PET/CT imaging was conducted by the Inveon small-animal PET/CT scanner (Siemens, Germany) equipped with the Inveon Research Workplace 4.1 software.
1)
The static micro-PET imaging studies were conducted with 3. 3) The dynamic micro-PET imaging studies were conducted with 3.7 MBq of 2D
(injection via the tail vein) on other C6 tumor-bearing BALB/c mice (n = 3) over a
